These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13629783)

  • 1. Biochemical alterations in blood in obliterative atherosclerosis.
    GIBINSKI K
    Circulation; 1959 Feb; 19(2):228-31. PubMed ID: 13629783
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood catecholamines in obliterative endarteritis and atherosclerosis].
    Ivanov VA; Kotlukova TV; Shcherbinin NM; Khairulina RV
    Khirurgiia (Mosk); 1973 Oct; 49(10):37-42. PubMed ID: 4776983
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rheodextran, vasodilating infusion and blood flow properties in patients with obliterative atherosclerosis of the lower extremities].
    Bulvas M; Linhart J
    Vnitr Lek; 1982 Sep; 28(9):902-7. PubMed ID: 6183828
    [No Abstract]   [Full Text] [Related]  

  • 4. [Certain biochemical alterations in the blood of patients with atherosclerosis obliterans of the lower limb arteries].
    Shval'b NG; Kalinin RE
    Angiol Sosud Khir; 2007; 13(3):34-7. PubMed ID: 18389577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood basocytes in obliterative arteriosclerosis of lower limbs].
    Gonciarz Z
    Pol Tyg Lek; 1967 Sep; 22(39):1480-2. PubMed ID: 6082508
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peripheral venous blood concentration of lactates and pyruvates in patients with obliterative arteriosclerosis].
    Geraga W; Czechowicz Z; Jarkowska J; Piotrowicz-Kasprzakowa K; Chmielnicka-Pruszczyńska M
    Wiad Lek; 1978 Apr; 31(7):441-7. PubMed ID: 664673
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinolytic activity of the blood in atherosclerosis obliterans of the lower extremities.
    Janda R; Cencora A; Jarosz B; Slezek Z
    Folia Histochem Cytochem (Krakow); 1967; 5(3):275-81. PubMed ID: 6078943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Surgical correction of hyperlipidemia in the treatment of arteriosclerosis obliterans].
    Ratner GL; Kalimullin KhA
    Khirurgiia (Mosk); 1993 Nov; (11):30-4. PubMed ID: 8145462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of a single dose of heparin on the fibrinolytic activity of plasma euglobulins and studies on blood coagulation in patients with obliterative arteriosclerosis of the lower extremities].
    Cencora A
    Folia Med Cracov; 1973; 15(2):207-27. PubMed ID: 4758953
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemodilution effect on the electrocardiogram and left-ventricular contraction dynamics in patients with obliterative arteriosclerosis].
    Dabrowski A; Daciewicz Z
    Pol Tyg Lek; 1982 Apr; 37(4-5):117-9. PubMed ID: 7111079
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood platelet function in patients with obliterative arteriosclerosis of the lower limbs.
    Bodzenta-Lukaszyk A; Krupiński K; Dabrowski S; Bielawiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):479-82. PubMed ID: 2465957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LATE RESULTS OF THROMBENDARTERECTOMY IN OBLITERATIVE ATHEROSCLEROSIS.
    SELVAAG O; SIVERTSSEN E; BERGAN F
    J Oslo City Hosp; 1964 Dec; 14():201-27. PubMed ID: 14255118
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of total cholesterol and its lipoproteic fractions in patients with coronary atherosclerosis, atherosclerosis obliterans and healthy controls in our environment].
    González Juanatey JR; Pose Reino A; Amaro Cendón A; Rubio Alvarez J; Otero Raviña F; Gil de la Peña M; Cabezas-Cerrato J
    Med Clin (Barc); 1985 Sep; 85(7):262-5. PubMed ID: 4058080
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemorheologic disturbances in patients with obliterative atherosclerosis of peripheral arteries and type 2 diabetes mellitus].
    Kulikova AN; Nesnova ES
    Klin Med (Mosk); 2009; 87(1):33-6. PubMed ID: 19256257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum zinc and copper in patients with atherosclerosis obliterans of the lower limbs].
    Uza C; Kovacs A; Vlaicu R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(6):509-13. PubMed ID: 6136075
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the blood coagulating system in obliterating atherosclerosis of the lower extremities].
    Kokhan EP; Khrushcheva EA; Zolotarevskiĭ VIa
    Lab Delo; 1969; 8():455-8. PubMed ID: 4193030
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipoproteins in the blood, atherosclerosis and thrombosis].
    Fasoli A
    Rev Atheroscler (Paris); 1967; 9(3):23-7. PubMed ID: 5593602
    [No Abstract]   [Full Text] [Related]  

  • 18. [General characteristics of shifts in the system of hemostasis in obliterating atherosclerosis].
    Elagin OS; Zherdeva LV; Alekseev GI
    Ter Arkh; 1982; 54(8):85-7. PubMed ID: 7135250
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
    Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
    [No Abstract]   [Full Text] [Related]  

  • 20. [TREATMENT OF OBLITERATIVE ENDARTERITIS AND ATHEROSCLEROSIS OF LOWER EXTREMITIES USING SUBCUTANEOUS INJECTION OF OXYGEN].
    EPOVA AA
    Voen Med Zh; 1964; 26():70-1. PubMed ID: 14295246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.